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ARTICLE
Altered thymic differentiation and modulation
of arthritis by invariant NKT cells expressing
mutant ZAP70
Meng Zhao1, Mattias N.D. Svensson2,3, Koen Venken4,5, Ashu Chawla6, Shu Liang7, Isaac Engel1, Piotr Mydel8,9,
Jeremy Day10, Dirk Elewaut4,5, Nunzio Bottini2,3 & Mitchell Kronenberg 1,11
Various subsets of invariant natural killer T (iNKT) cells with different cytokine productions
develop in the mouse thymus, but the factors driving their differentiation remain unclear.
Here we show that hypomorphic alleles of Zap70 or chemical inhibition of Zap70 catalysis
leads to an increase of IFN-γ-producing iNKT cells (NKT1 cells), suggesting that NKT1 cells
may require a lower TCR signal threshold. Zap70 mutant mice develop IL-17-dependent
arthritis. In a mouse experimental arthritis model, NKT17 cells are increased as the disease
progresses, while NKT1 numbers negatively correlates with disease severity, with this pro-
tective effect of NKT1 linked to their IFN-γ expression. NKT1 cells are also present in the
synovial fluid of arthritis patients. Our data therefore suggest that TCR signal strength during
thymic differentiation may influence not only IFN-γ production, but also the protective
function of iNKT cells in arthritis.
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Invariant natural killer T cells (iNKT cells) are a populationthat expresses an invariant TCR α chain, encoded by a Trav11-Traj18 rearrangement in mice. They also express a limited set
of Trbv genes, although unlike for the α chain, there is substantial
CDR3β diversity as a result of gene rearrangement. iNKT cells
recognize glycolipid antigens from microbial, environmental and
even autologous sources when presented by CD1d, a non-
polymorphic class I-like antigen presenting molecule1. Their
rearranged α chain is conserved in a number of mammalian
species, including humans, as is the specificity of iNKT cells2,
suggesting they have an important function. An unusual property
of iNKT cells is their innate-like responses, typified by the rapid
secretion of large amounts of cytokines after TCR stimulation3.
They also can respond rapidly when exposed to certain cytokines,
similar to NK cells and other ILC populations. For example, the
combination of IL-12 and IL-18 will stimulate IFN-γ synthesis by
iNKT cells4,5.
iNKT cells have been reported to influence many types
of immune responses, including chronic inflammatory conditions
and autoimmunity6. A puzzling feature, however, is that in
some cases iNKT cells stimulate immunity and inflammation
and have a detrimental influence, while in other situations they
can be anti-inflammatory and beneficial. Considering rheumatoid
arthritis (RA) models induced by immunization, for example
collagen-induced arthritis (CIA), or induction by serum transfer,
in most studies iNKT cells had a disease promoting effect.
Therefore, mice without iNKT cells were better off in several
studies, although this was not true in some other reports7.
Their role in patients is unproven, but iNKT cells consistently
are decreased in the peripheral blood of those with RA6.
One possible contributor to the divergent effects of iNKT cells
is that there could be a selective differentiation in the thymus or
selective expansion or peripheral activation of functional subsets
of these cells. Subsets of iNKT cells include NKT1, NKT2, and
NKT17 cells, analogous to CD4+ TH1, TH2, and TH17 cells,
respectively8. An important difference with CD4+ T lymphocytes,
however, is that these functional subsets differentiate in the
thymus. The mechanism is unknown that causes iNKT cells, with
their limited TCR diversity and highly similar specificities, to
differentiate in the thymus to specialized effector populations
with highly different transcriptomes.
To investigate the possible influence of TCR strength in the
differentiation of a polyclonal iNKT cell population, we analyze
two strains of mice in which the function of the ζ-chain-
associated protein kinase 70 (ZAP70) is reduced. ZAP70 is a
tyrosine kinase that phosphorylates the linker of activated T cells
(LAT) and the SH2 domain-containing leukocyte protein of 76
kDa (SLP-76), and therefore has an important role in early TCR
signaling events. One of the strains we analyze is the SKG mouse,
which has a spontaneous mutation in an SH2 domain of ZAP70
that generates a hypomorphic allele. SKG mice have altered
thymic selection leading to the generation of arthritogenic Th17
cells9,10. The other strain (ZAP70AS) has an analog-sensitive(AS)
allele of ZAP7011.
In analyzing these mice, we demonstrate that ZAP70 influences
not only the number of iNKT cells, but also affects the proportions
of iNKT cell subsets and the way in which they function. Fur-
thermore, using the SKG mice, we demonstrate that iNKT cells are
capable of localizing to synovial tissue and preventing severe
arthritis, in part through production of IFN-γ. Therefore, under-
standing the role of different iNKT cell subsets could help design
new therapeutic interventions for rheumatoid arthritis patients.
Results
TCR signaling genes differ in iNKT cell subsets. The different
patterns of iNKT cell cytokine secretion could be critical for
understanding the diverse functions that have been attributed to
these cells. In order to understand how functional subsets of
iNKT cells arise, we evaluated the transcription programs in
subsets of thymus iNKT cells12. Because TCR avidity plays an
important role in the development of CD4 and CD8 cell
populations, as well as agonist selected iNKT cells, we analyzed
if the expression of genes related to the TCR signaling pathway
differed among iNKT cell subsets. A Gene Set Enrichment
Analysis (GSEA) of the RNA-seq results revealed that TCR sig-
naling genes were significantly enriched in NKT1 thymocytes
compared to NKT2 cells or NKT17 (Fig. 1a; Supplementary
Fig. 1a), and were significantly enriched in NKT17 compared
to NKT2 cells (Supplementary Fig. 1a). These data indicate tha-
t iNKT cell subsets activated different transcriptional programs
for genes in the TCR signaling pathway after their generation
in the thymus. We also observed the highest TCRβ staining
as well as antigen-loaded CD1d tetramer staining in NKT2 cells,
intermediate in NKT17 and lowest in NKT1 (Supplementary
Fig. 1b), consistent with a previous publication13. We grouped
the differentially expressed (DE) genes (adjusted p <= 0.1,
fold change >= 1.5) according to relative expression levels in
the subsets (Fig. 1b; Supplementary Fig. 1c). Several genes in
the NF-κB pathway, including Rela, Bcl10, Malt1 and
inhibitors Nfkbib and Cblb were among the NKT1 enriched genes
(Fig. 1b). This was consistent with the selective defect in
CD44hiNK1.1+ (stage 3) iNKT cells, which are mostly NKT1
cells, in IκBαtg14 and PKCθKO15 mouse strains that both have
impaired NF-κB signaling. It has been shown that PLZF was
induced during thymic development by Egr2 downstream of
NFAT signaling16. Expression of Egr2 and Nfatc1 was highest
in NKT2 cells. Egr1 and Nfatc3 were preferentially expressed
in NKT17 cells, but also higher in NKT2 compared to
NKT1 cells. Several activation markers typically associated with
a strong interaction of TCR and cognate antigens, such as Icos17
and Pdcd118 were also more highly expressed in NKT2
and NKT17 cells, or selectively in NKT2, such as Cd519. Con-
versely, negative regulators for TCR signaling, including,
Ptpn2220, Pag121, Ptpn622, Ptprc23, Lat224, and Ubash3a25,26 were
more highly expressed in NKT1 cells (Fig. 1b). These results
suggest that unique gene signatures in iNKT cell subsets were
induced during development. Based on this, we hypothesized
that the development or maintenance of NKT1 cells required a
lower strength of TCR signals.
Reduced iNKT cells in ZAP70 mutant mice. To test the signal
strength hypothesis further, we analyzed SKG mice, which harbor
a spontaneous point mutation in the Zap70 gene that results in
reduced TCR signals, defective thymic selection of autoimmune
T cells and eventual development of inflammatory arthritis
dependent on IL-17 secretion9. The percentages of iNKT cells in
CD8− thymocytes in SKG and WT BALB/c control mice were
comparable (Fig. 1c), but in agreement with a previous report9,
there was decreased positive selection of CD4 and CD8 T cells in
these mice. Therefore, the percentage of iNKT cells in total live
thymocytes and the number of iNKT cells in SKG thymus were
significantly lower (Fig. 1d, e).
We carried out several experiments to determine the cause of
the reduced iNKT cell frequency. The expression of CD1d by
SKG DP thymocytes, the cell type that positively selects
iNKT cells, was not reduced (Supplementary Fig. 1d), suggesting
the decrease could be cell intrinsic. Mutations that affect the
survival time of DP thymocytes can cause a cell-intrinsic decrease
in iNKT cells, due to the decreased formation of the iNKT cell
TCR α chain27,28. This is because the Trav11 and Traj18 gene
segments in the α locus are in distal locations and their joining
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in DP cells usually requires the secondary TCR α locus
rearrangements dependent on normal DP survival. The average
number of DP cells in 8-week-old mice, however, was comparable
in WT and SKG strains (Supplementary Fig. 1e). Furthermore,
the rate of incorporation of BrdU into the newly synthesized
DNA of DP thymocytes was similar comparing SKG and WT
mice (Supplementary Fig. 1f). Using AnnexinV (AnV) staining to
measure apoptotic cells, there were decreased AnV+ cells in SKG
mice (Supplementary Fig. 1g), implying that DP cells may survive
even longer than in WT mice.
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To determine if TCR α locus rearrangements were skewed
away from distal gene segments, we examined the Traj usage of
Trav11 rearrangements in CD69−, CD5− pre-selection DP
thymocytes by sequence analysis. As controls, we also analyzed
rearrangement of Trav19, which is one of the most Traj proximal
Vα segments (Supplementary Fig. 2a), and Trav9d-3 located
towards the distal region. Trav9 has been shown to rearrange
much less frequently to distal Traj genes in HEB knockout mice,
which have impaired DP survival27. Considering productive
reads, Trav19 preferentially used the proximal Traj genes in
BALB/c and SKG mice (Supplementary Fig. 2b), consistant with
results from pre-immune CD8 T cells29, while Trav9d-3 used
distal ones (Supplementary Fig. 2c). The Trav11-Traj18 rearran-
gement accounted for ~10% of total reads from Trav11 amplicons
in SKG mice, the same frequency as in WT mice (Supplementary
Fig. 2d), showing that the decrease of iNKT cells (Fig. 1d, e) was
not due to reduced generation of the invariant TCRα chain
rearrangement. Comparing Traj rearrangements in WT and SKG
mice for all three Trav genes, a significant bias for distal Traj
rearrangements in SKG DP thymocytes was observed, (Supple-
mentary Fig. 2e–g). The hypomorphic Zap70 mutation in
SKG mice dampened TCR signaling in DP cells, as reflected by
reduced free calcium flux into the cytoplasm upon TCR
stimulation (Supplementary Fig. 2h). Therefore, it is possible
that generation of a TCR that passes the threshold of positive
selection may require more rounds of TCRα rearrangement in the
DP cells from SKG mice, leading to a higher frequency of
rearrangements to the distal Traj segments. This may compensate
for the reduced TCR signal strength, limiting the decrease in the
iNKT cell population in these mice.
Skewed iNKT cell subsets in Zap70 mutant mice. The reduction
in the MFI of TCRβ and CD1d-αGC tetramer staining (Fig. 1c),
suggested that NKT1 cells could be more abundant in thymic
SKG iNKT cells. Staining for transcription factor expression in
thymic iNKT cells confirmed the enrichment of NKT1 cells
(PLZFloRORγt−) in SKG mice (Fig. 1f), whereas NKT2 and
NKT17 cells were much reduced (Fig. 1f–h). Consistent with the
change in the subsets, T-bet expression in total iNKT cells was
much higher, and PLZF and RORγt were diminished (Fig. 1i).
The chemokine receptor CXCR3 has been shown to be most
highly expressed by NKT1 cells12, and its expression was much
higher in total SKG iNKT cells. PD-1, a marker for the NKT2/
17 subsets (Supplementary Fig. 1c) had reduced expression in
SKG iNKT cells (Fig. 1j). NKT2 cells capable of producing IL-4
under homeostatic conditions have been shown to be critical for
the differentiation of innate, memory-like CD8 T cells that
express Eomes instead of T-bet, and a high level of CD12230.
Consistent with the relatively few NKT2 cells in SKG thymus,
innate memory CD8 T cells were barely detectable in these mice
(Fig. 1i, k).
When stimulated directly ex vivo on microwells coated with
mouse CD1d and loaded with αGC, SKG iNKT cells were
defective at producing different cytokines, including IFN-γ as well
as IL-4 and IL-17 (Supplementary Fig. 3a), likely reflecting the
ZAP70-hypomorphic nature of SKG mutation. When using
Phorbol 12-myristate 13-acetate (PMA) and ionomycin stimula-
tion to bypass proximal TCR signaling events, however, we
observed higher IFN-γ and lower IL-4 and IL-17 production
(Supplementary Fig. 3b), likely a result of the increased
NKT1 cells in SKG mice. The analysis of mixed bone marrow
chimeric mice (Fig. 1m; Supplementary Fig. 3c, d), generated
using equal numbers of SKG(CD45.2) and WT(CD45.1) bone
marrow donor cells, demonstrated that the defect in iNKT cell
subset development was predominantly cell instrinsic, as the SKG
iNKT cells of the chimeric mice showed similar defects as in the
intact mice.
Skewed SKG iNKT cell differentiation in organ cultures. Fetal
thymic organ culture (FTOC) is a powerful tool to study T cell
development in vitro31–33. We tested if iNKT cell subsets would
be observed in this system. Analyzing intact mice we confirmed
that iNKT cells did not appear in the thymus until several days
postnatal age34. Therefore, we used E18.5—day 0 animals from
BALB/c mice cultured for 1 week in vitro. iNKT cells could be
detected from day 4 in culture and their percentage in total
thymocytes gradually increased in the following days (Fig. 2a, b).
On day 4, iNKT cells were mostly PLZFhi T-betlo and PD-1hi,
consistent with the phenotype of iNKT cells from 3-day-old mice
in vivo (Supplementary Fig. 4a, b). T-bet expression rapidly
increased in the next 24 h. By day 6, the T-bethi population
increased, including cells that retained high expression of the
NKT2 marker PD-1, other cells with decreased PD-1 and even
some with expression of the NKT1 cell marker CXCR3. Ontogeny
studies of iNKT cell phenotype from the thymus of very young
animals showed a similar phenotypic progression (Supplementary
Fig. 4a, b). We did not detect RORγt expression in the organ
cultures and NKT17 cells were a very minor population in 3-day-
old or 4-day-old mice. We also cultured thymus tissue from
Nur77gfp mice, which express a reporter for TCR signal
strength35. Total iNKT cells, as reported, showed very low GFP
signal compared to CD4 T cells, but stage 0 iNKT cells (CD24hi
CD44− NK1.1−) expressed high level of GFP (Supplementary
Fig. 4c, d). In FTOC, we observed a higher GFP signal from the
PD1hiNK1.1− population that resembles NKT2 cells (Fig. 2c, d).
These Nur77gfp high expressing NKT2 cells have been reported to
produce IL-4 in vivo at steady state36. This is also consistent with
the higher transcription of Nfatc1, Egr2, and Pdcd1 in NKT2 cells,
as shown in Supplementary Fig. 1c. We compared cultures of
thymus tissue from day 0 SKG and WT animals. The SKG
iNKT cells in the culture expressed a higher amount of CXCR3
and lower PD-1 (Fig. 2e), in line with the NKT1 skewed phe-
notype of SKG mice. Therefore, overall FTOC cultures recapi-
tulated some important features of iNKT cell development and
the subset alterations in SKG mutant mice, indicating that
Fig. 1 iNKT cells are skewed to NKT1 phenotype in SKG ZAP70 mutant mice. a Gene set enrichment analysis of 216 TCR signaling pathway-related genes
comparing the transcriptomes of thymic NKT1 and NKT2 cells from BALB/c mice. b Differentially expressed TCR pathway genes enriched in NKT1 cells
from triplicate RNA-seq runs are shown in a heatmap. c–e Decreased thymic iNKT cells in SKG mice. c Representative staining of iNKT cells gated as
TCRβint, CD1d-αGC tetramer+ cells in live, CD8-negative thymocytes from WT and SKG mice. d Percentages and e absolute numbers of thymic iNKT cells
in the WT and SKG mice. f iNKT cell subsets were gated as PLZFlo RORγt− (NKT1), PLZFhi RORγt− (NKT2), and PLZFintRORγt+ (NKT17). g Percentages in
total iNKT cells and h absolute numbers of the iNKT cell subsets in WT and SKG mice. i, j Expression of the indicated transcription factors and surface
markers CXCR3 (NKT1 marker) and PD-1 (NKT2) marker in total WT or SKG iNKT cells. k Innate-like CD8 T cells, gated as Eomes+ CD122+ in CD8
+CD3εhi thymocytes. l Absolute numbers of innate-like CD8 T cells in WT and SKG mice. m Thymic iNKT cell subsets from mixed bone marrow chimera
mice. Percentages of iNKT subsets from either WT (CD45.1) or SKG (CD45.2) donors were plotted. c–m Data are representative from one of at least three
independent experiments. Graphs represent mean ± SD with symbols representing individual mice. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; n.s.
not significant (unpaired two-tailed Student’s t test)
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migration of mature T cells back to the thymus cannot explain
the iNKT cell phenotype in the thymus of SKG mice.
Skewed iNKT cell development in ZAP70AS mice. The SKG
mutation in the second SH2 domain of ZAP70 affects its binding
to phosphorylated ITAMs. To examine more directly the effect of
the kinase activity of ZAP70 in lowering the strength of TCR
signaling during iNKT cell development, we utilized mice
expressing an engineered, analog-sensitive ZAP70 (ZAP70AS),
whose catalytic activity can be specifically targeted by small
molecule inhibitors37. Although ZAP70AS is a hypomorphic
mutant, with a catalytic activity approximately one third of the
WT protein37, it has been shown that mice that expressed this
allele reconstituted a normal T cell population in ZAP70 null
mice11. Because AS mice were on the C57BL/6 background,
which is NKT1 biased36, NKT1 cells were the major subset in this
strain (60% of total iNKT cells in WT mice, Fig. 3a). Interestingly,
similar to the comparison of SKG mice with their parental BALB/
c strain, NKT1 cells in AS mice were more prevalent (Fig. 3a, b).
In agreement with this, we observed changes in expression of
the transcription factors T-bet and PLZF, as well as subset
markers CXCR3 and PD-1, that were in an NKT1-biased direc-
tion in AS and SKG mice when compared to their WT controls
(Figs. 1i, j and 3c, d).
Inhibition of ZAP70 kinase decreases NKT2 cells. We tested if
small molecule inhibition of ZAP70 catalysis in FTOC would
further affect iNKT cells (Fig. 3e–h). Thymus lobes from day 0
animals were cultured in the presence of DMSO or the inhibitor
3-MB-PP1. After 7 days of culture, T lymphocytes including
iNKT cells were greatly diminished, even at the lowest con-
centration tested (Supplementary Fig. 5a–c). This is in line with
the requirement for the ZAP70 kinase during positive selection38.
Addition of the inhibitor 48 h after the initiation of the culture,
however, allowed for a similar percentage of iNKT cells (Sup-
plementary Fig. 5d). These data implied that ZAP70 catalytic
activity is required during the commitment to become an iNKT
cell, but perhaps less so during the expansion phase of these cells
that occurs later. Importantly, the percentage of iNKT cells that
were Tbethi in the iNKT cell population in cultures exposed to
inhibitor from day 2 did not change compared to DMSO treated
controls, while the expression of PLZF was reduced in a dose-
dependent manner (Fig. 3e, f). We also consistently observed a
higher sensitivity of expression of the NKT2/NKT17 marker PD-
1 to chemical inhibition, and in contrast, a higher inhibitor tol-
erance for expression of the NKT1 marker CXCR3 (Fig. 3g, h),
which is under the control of T-bet39. Overall, these results
demonstrated that PLZF expression and the NKT2 population
were more sensitive to diminution of TCR signaling, and con-
versely, that NKT1 cells can withstand a lower TCR signal
strength.
NKT1 cells are similar to wild type in SKG mice. We performed
RNA-seq to compare the global gene expression pattern of thymic
iNKT cell subsets from WT and SKG mice. We defined the
subsets by surface expression of several proteins, as descri-
bed12,36,40 (Online methods and Supplementary Fig. 6). The
expression pattern of signature transcription factors was used to
confirm enrichment of each subset. Principal component analysis
(PCA) of the RNA-seq data showed three clearly distinct iNKT
cell populations (Fig. 4a). Importantly, each subset from SKG
mice clustered together with its WT counterpart. In particular,
NKT1 thymocytes from SKG mice were in close proximity to WT
NKT1 thymocytes in the PCA plot, suggesting that the very
predominant NKT1 cell subset in SKG mice was comparable to
WT NKT1 cells. In agreement with this, there were only 158
genes with a greater than 1.5-fold change in expression com-
paring SKG and WT in NKT1 cells, with 101 of these down in
SKG NKT1 cells, whereas much greater numbers of genes dis-
tinguished the NKT2 and NKT17 thymocytes from these strains
(Supplementary Fig. 7a–c).
Reduced inhibitory receptors in SKG NKT1 cells. Pathway
enrichment analysis of the differentially expressed genes in NKT1
thymocytes from the two mouse strains revealed that the TCR
signaling pathway was significantly affected, with reduced
expression of inhibitory receptors and genes that have the
potential to inhibit signal transduction in SKG NKT1 cells. For
example, there was lower expression of the genes encoding
inhibitory surface proteins Pdcd1, Tigit, Cd160, and Cd5 in SKG
NKT1 cells compared to WT NKT1 cells (Fig. 4d). Natural killer
(NK) receptors have been shown to be NKT1-specific markers in
both BALB/c and C57BL/613 mice, and interestingly NK cell-
mediated cytotoxicity showed the highest significant p value in
the pathway analysis (Fig. 4b). As published previously34,41, the
majority of NK receptor genes that were highly transcribed in
WT NKT1 cells encode inhibitory receptors, including Klrd1/
CD94, Klra5/Ly49e, Klra3/Ly49c, Klra1/Ly49a, Klrc1/NKG2A,
and Klra7/Ly49G (Fig. 4c). We found that transcription of
most NK receptors was significantly reduced in SKG iNKT1
thymocytes compared to WT counterparts. This is consistent
with the requirement for TCR signaling for the upregulation of
these receptors42–44. WT iNKT cells also expressed the activating
NK receptors NKG2D and NKp46, however, Klrk1 transcripts
(NKG2D) did not differ in SKG NKT1 cells (Fig. 4c) and
Ncr1 (NKp46) was transcribed at a low level in both strains.
Genes related to T helper cell differentiation and function,
including the IFN-γ and IL-4 signaling pathways and JAK/STAT
pathways involved in cytokine signaling were also altered in SKG
NKT1 cells (Fig. 4b) as was expression of Lat2, Sprouty, Tnfaip3,
and Socs3 (Fig. 4d). LAT2 is a transmembrane adaptor protein
closely related to LAT, but its deletion resulted in hyper-activated
T cells and autoimmune disease24. Sprouty2 (Spry2) is a negative
regulator of receptor tyrosine kinase signaling45–47. TNFAIP3
(A20) is a ubiquitin-editing enzyme that suppresses NF-κB
activation. Suppressor of cytokine signaling 3 (SOCS3) SOCS3 is
capable of inhibiting STAT4, which is activated by IL-1248, and
therefore, can potentially influence NKT1 function. Therefore,
compared to WT NKT1 thymocytes, SKG NKT1 cells have
reduced expression of inhibitory receptors and molecules
involved in the inhibition of signal transduction, perhaps a
necessary compensation for the reduced TCR signaling capacity
resulting from the SKG Zap70 mutation.
Increased NKT1 cells in the spleen of SKG mice. The difference
in iNKT cell subsets in SKG mice was not confined to the thymus.
We found a similar difference in TCRβ expression (Supplemen-
tary Fig. 8a, b). However, unlike in the thymus, we observed an
increase in splenic iNKT cells, both in percentage and cell
numbers (Supplementary Fig. 8c, d). Perhaps this expansion is
related to the decrease in mainstream CD4 and CD8 T lym-
phocytes in SKG mice. Importantly, the increase was due to
augmented splenic NKT1 cells, and there was no elevation in the
relatively minor populations of splenic NKT2 and NKT17 cells
(Supplementary Fig. 8e–g). This was reflected by the expression
level of signature transcription factors and surface markers
(Supplementary Fig. 8h, i). Furthermore, consistent with the
thymus RNA-seq data (Fig. 4c, d), splenic SKG iNKT cells
showed reduced expression of inhibitory molecules CD160,
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NKG2a/c/e, and Ly49G2 when compared to WT iNKT cells
(Supplementary Fig. 8j).
iNKT cells prevent severe arthritis in SKG mice. Spontaneous
arthritis in SKG mice can be accelerated by the injection of the
fungal cell-wall component mannan10. To determine if iNKT cells
have an active role in pathogenesis in SKG mice, we evaluated the
presence of iNKT cells in ankles and joint-draining lymph nodes
following mannan injection during the course of arthritis.
Although the percentage of iNKT cells did not increase due to the
influx of other cells, the number of iNKT cells increased in ankles
as arthritis progressed, and this number was significantly
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correlated with the disease-associated change in ankle thickness
(Fig. 5a, b). Furthermore, expression of the activation marker
CD69 was significantly increased on ankle iNKT cells during
arthritis development (Fig. 5c). A similar correlation between
the number of iNKT cells and the clinical severity of arthritis,
as well as an increased expression of CD69 by iNKT cells, was
observed in joint-draining lymph nodes (Supplementary Fig. 9a,
b). Together, these data suggest iNKT cells might play a sig-
nificant role in arthritis in SKG mice.
To assess the role of iNKT cells more directly, we evaluated
arthritis development in iNKT cell-deficient (Cd1d−/−) and iNKT
cell sufficient (Cd1d+/−) SKG mice. The absence of iNKT cells
significantly aggravated the development of arthritis, with regard
to clinical signs, histopathological scoring of synovial inflamma-
tion, bone destruction and cartilage depletion (Fig. 5d, e). Further
visual evaluation of bone morphology by micro-CT analysis
confirmed increased signs of bone destruction in iNKT cell-
deficient SKG mice (Fig. 5f). These results strongly suggest that
iNKT cells were necessary to protect against severe arthritis
development in SKG mice.
Deficiency of CD1d in SKG mice could potentially create
an empty developmental niche in which other T cells could
differentiate and expand, or it could affect CD1d reactive cells
with more diverse TCRs. To circumvent this, we acutely deleted
iNKT cells from WT SKG mice using NKT14, an antibody that
specifically depletes iNKT cells based on reactivity to the
invariant TCR α chain49. We verified the efficacy of iNKT cell
depletion in joint-draining lymph nodes of the antibody treated
mice by flow cytometry (Fig. 5g). Similar to Cd1d−/− SKG mice,
antibody depletion of iNKT cells was associated with significantly
aggravated arthritis development (Fig. 5h, i). Together, these
results show that iNKT cells were required to protect SKG
mice from the development of severe arthritis.
To confirm a suppressive effect of iNKT cells on arthritis
pathogenesis, we transferred CD4+ SKG T cells alone or in
combination with SKG iNKT cells to BALB/c Rag2−/− mice and
induced arthritis by mannan injection 1 week after cell transfer
(Fig. 5i). Consistent with the known dependence of arthritis
on T lymphocytes, transfer of CD4+ SKG T cells promoted
arthritis development in Rag2−/− mice (Fig. 5j, k). Importantly,
the severity of arthritis was significantly reduced in the presence
of SKG iNKT cells, confirming that they have the capacity to
ameliorate disease (Fig. 5k).
Changes of iNKT cell subsets during arthritis development.
The positive correlation between increased joint iNKT cells and
arthritis progression led us to investigate if local iNKT cells
retained protective function during disease. We hypothesized
that different iNKT cell subsets might have distinctive roles as
pathogenesis progresses. We therefore assessed the dynamics of
iNKT cell subsets in SKG joints and draining lymph nodes at
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different stages of arthritis development. Activation of cytokine
production by PMA and ionomycin treatment of iNKT cells
from arthritic SKG mice revealed that iNKT cells with the
capacity to produce IFN-γ (NKT1), IL-4 (NKT2), and IL-17A
(NKT17) all were present in joint-draining lymph nodes, with
some IFN-γ plus IL-4 double producers, typical of NKT1 cells.
In arthritic joints, however, only iNKT cells capable of producing
IFN-γ (NKT1) or IL-17A (NKT17) were present (Fig. 6a). In
SKG arthritic ankles, we observed a gradual decline in the
frequency of NKT1 cells and an increased frequency of NKT17
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cells during disease progression (Fig. 6b). Importantly, joint
NKT1 cell and NKT17 cell frequencies displayed opposite cor-
relations with the severity of arthritis, as measured by changes in
ankle swelling (Fig. 6c), with increased NKT17 cells correlating
with severity. A progressive increase in NKT17 cell frequency in
joint-draining lymph nodes also correlated with the clinical
severity of arthritis (Supplementary Fig. 9c–e). However, lymph
node NKT1 or NKT2 cell frequencies underwent only minor
changes during the course of arthritis that did not correlate with
disease severity (Supplementary Fig. 9c–e). Therefore, changes in
the frequencies of joint iNKT cell subsets occurred during the
course of arthritis. Furthermore, these data suggest that
NKT1 cells may mediate the protective activity of iNKT cells in
SKG arthritis.
Impaired IFN-γ from RA synovial fluid iNKT cells. Previous
reports have identified iNKT cells in the synovial fluid (SF) and
synovial tissue (ST) of rheumatoid arthritis (RA) patients50,51.
We confirmed that iNKT cells were present in the SF of patients
with RA (Fig. 6e; Supplementary Table 1). Defined functional
subsets of iNKT cells, namely NKT1, NKT2, and NKT17, are not
as well defined in humans, but we tested the ability of iNKT cells
from paired SF and peripheral blood (PB) to produce IFN-γ upon
exposure to αGC. IFN-γ production from SF iNKT cells was
significantly lower than from matched PB samples (Fig. 6f).
Although this could be due to an impaired antigen presentation,
stimulation with PMA and ionomycin confirmed a reduced
presence of IFN-γ producing iNKT cells in the SF compared to
the blood (Fig. 6g). Together with the results obtained from SKG
mice, these results are consistent with the hypothesis that active
arthritis is correlated with a decreased ability to produce IFN-γ by
iNKT cells or reduced NKT1 cells in joint tissue.
Unimpaired response to cytokines from SKG iNKT cells.
Consistent with the known dampening effect of the Zap70SKG
mutation on TCR-signaling, SKG thymic iNKT cells displayed a
reduced response to TCR activation in vitro (Supplementary
Fig. 3a). Additionally, we found that splenic SKG iNKT cells had
reduced production of IFN-γ and IL-4 in response to αGC
injection in vivo (Fig. 6h), although the decrease in IFN-γ pro-
ducing SKG iNKT cells was much less drastic than for IL-4
(Fig. 6h). NKT1 cells also can undergo TCR-independent,
cytokine-mediated activation, most efficiently in response to IL-
12 plus IL-18 or to LPS52. Activated in this way, NKT1 cells
produce IFN-γ, but not the mixed, Th0 pattern of IFN-γ plus IL-
4, combined with other cytokines, that results from αGC injection
into mice. We therefore compared the in vivo iNKT cell response
to LPS in WT and SKG mice. LPS promoted an increased
percentage of cells with intracellular IFN-γ from splenic
iNKT cells of SKG mice compared to WT mice, likely reflective
of the increased number of NKT1 cells (Fig. 6i). This difference
was consistent with significantly increased serum levels of IFN-γ
6 h after LPS injection (Fig. 6j). No difference in IFN-γ produc-
tion from trans activated NK cells, meaning NK cells that were
activated as a result of iNKT cell stimulation, was observed
between SKG and WT mice (Supplementary Fig. 9f). Further-
more, cultures of peripheral lymph node cells revealed that
iNKT cells from pre-arthritic or arthritic SKG mice showed an
enhanced IL-12-induced expression of IFN-γ by intracellular
cytokine staining (Fig. 6k), despite having a less pronounced
increase in NKT1 cells compared to thymus or spleen (Supple-
mentary Fig. 9g, h). Together these results suggest that despite
having reduced antigen sensitivity of their TCR, SKG iNKT cells
showed an increased IFN-γ response to cytokine-mediated
activation.
iNKT cells suppress arthritis through IFNγ. IFN-γ is protective
in several models of arthritis, including the SKG model53,54. Due
to the enrichment of NKT1 cells in SKG mice, we therefore
hypothesized that the arthritis-ameliorating effect provided by
iNKT cells could be mediated through the production of IFN-γ.
To evaluate this hypothesis, we activated iNKT cells from WT
and Ifng−/− (IFN-γ-KO) SKG mice using αGC on the same day
as arthritis induction by mannan. Injection with αGC in WT mice
caused a significant reduction in arthritis development when
compared to PBS treated controls (Fig. 7a). However, αGC
injection did not affect arthritis development in IFN-γ-KO SKG
mice (Fig. 7b), despite the induction of other cytokines by αGC
injection, suggesting that the protective effect provided by
iNKT cells required IFN-γ.
Although our results indicate that activation of IFN-γ
production by iNKT cells might provide a therapeutic regimen
for RA, injection of αGC into SKG mice with established arthritis
did not reduce disease (Supplementary Fig. 10a). αGC is a very
potent antigen for iNKT cells, but we reasoned that due to its
activation of many cytokines, the relative paucity of NKT1 cells in
the joints when arthritis is established, or the poor TCR signaling
by SKG iNKT cells, that this antigen might result in insufficient
IFN-γ production. The glycolipid antigen 7DW8-5, with a para-
fluoro-phenyl modification of the αGC sphingosine base, has
previously been described to elicit an even stronger Th1-biased
response than αGC55. Treatment with 7DW8-5 on the day of
mannan injection also prevented the development of arthritis in
SKG mice (Supplementary Fig. 10b). Importantly, therapeutic
treatment of arthritic SKG mice with 7DW8-5 significantly
reduced the progression of arthritis (Fig. 7c).
Fig. 5 iNKT cells suppress arthritis. a Representative flow cytometry plots of iNKT cells (TCRβint CD1d-αGC tetramer+ in live CD8−CD19− cells), in ankles
of SKG mice during the course of arthritis. Day 0 (circle), day 12 (square), day 22 (triangle), and day 47 (diamond) post-mannan injection. b Number of
iNKT cells in ankles (left panel) and correlation with ankle swelling (right panel) during the course of arthritis in SKG mice. c Expression of CD69 on ankle
iNKT cells during the course of arthritis in SKG mice. d Clinical score (left panel) and change in ankle thickness (right panel) in Cd1d−/− (n= 6) and Cd1d+/−
(n= 8) male SKG mice after injection of mannan. e Histological evaluation of synovial inflammation (S), bone erosion (E), and cartilage destruction in arthritic
ankles from Cd1d−/− (n= 6) and Cd1d+/− (n= 8) SKG mice. Scale bar 500 μM. f Representative Micro-CT of ankles from arthritic Cd1d−/− and Cd1d+/− SKG
mice. White arrow indicates bone erosion and reactive bone formation which is increased in CD1d−/− SKG mice. g Representative flow cytometry plots of
iNKT (gated as in a) cell depletion efficacy in lymph nodes after injection with iNKT cell-depleting (NKT14)mAb. h Clinical score (left panel) and change
in ankle thickness (right panel) in male SKG mice treated with NKT14mAb (n= 5) or isotype control (n= 6) after injection of mannan. Arrows indicate
time of injection. i Histological evaluation of synovial inflammation (S), bone erosion (E), and cartilage depletion in male SKG mice treated with control
or NKT14mAb. Scale bar 500 μM. j, k Transfer of CD4+ SKG T cells (1 × 106) alone (n= 7) or in combination with SKG iNKT cells (3 × 105) to Rag2−/− mice
(n= 7) and the clinical score (k, left panel) and change in ankle thickness (k, right panel) after injection of mannan. Representative data from two independent
experiments shown in a–c. Complied data from at least two independent experiments are shown in d, e, h, i, k. Graphs represent mean ± SEM with symbols
representing individual mice. *p < 0.05, **p < 0.01 (Mann–Whitney on area under the curve (d, h, k), Mann–Whitney (e, i), One way ANOVA (b, c), Spearman
correlation (b)
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Discussion
We have shown that decreased TCR signal strength due to Zap70
mutations affected the number of thymus iNKT cells, and more
strikingly, led to a predominance of NKT1 cells. Furthermore, we
demonstrated that the IFN-γ induced by iNKT cell activation
protected from severe arthritis in ZAP70 mutant mice, although
the representation of potentially protective NKT1 cells dimin-
ished in the ankles as disease progressed. Therefore, our data
show that a central immune defect, an alteration in thymic
selection due to reduced TCR signal strength, led not only to
arthritogenic Th17 cells, as reported previously9,10, but also to an
increased NKT1 population that ameliorated the most severe
form of disease.
On account of their limited TCR repertoire, it is surprising that
thymic iNKT cells can differentiate into functional subsets. Dif-
ferences in TCR signal strength could be an influence on iNKT
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Lymph node cultures prepared from WT BALB/c (blue), pre-arthritic SKG (red, 7–8 weeks old) and arthritic SKG mice (black, 40 days post-mannan
injection). Representative of at least two independent experiments are shown. Graphs represent mean ± SEM with symbols representing individual
mice. *p < 0.05, **p < 0.01 ***p < 0.001. (One way ANOVA (c,k), paired two-tailed t test (f), unpaired two-tailed Student’s t test (h–j), Spearman
correlation test (d))
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cell subset formation, however, considering the diversity of iNKT
cell β chains and other factors that might affect TCR avidity for
selecting ligands. Here we have analyzed the broad iNKT cell
population and show that TCR signal strength does influence
iNKT cell subsets. Although iNKT cells are agonist selected,
NKT1 cells were favored when TCR signaling was lessened due to
a hypo-functional ZAP70 protein. Moreover, using FTOC, we
have shown that catalytic inhibition of ZAP70 after culture
initiation reduced the high expression of PLZF and characteristic
NKT2 cell surface proteins in iNKT cells, whereas expression of
proteins characteristic of NKT1 cells was spared. These results
indicated that continuing strong TCR signals were required for
the maintenance of high amounts of PLZF, whereas NKT1 cell
differentiation withstood the lower TCR signals. Given that Egr2
can directly bind to the Il2rb locus encoding CD12216, we spec-
ulate that the TCR signal strength in SKG mice was sufficient to
increase the required amount of CD122 in differentiating and
expanding populations of NKT1 cells, but not enough to
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Fig. 7 NKT1-biased activation suppresses progression of arthritis in SKG mice. a Clinical score (left panel) and change in ankle thickness (right panel) in
WT (Ifng+/+) SKG mice with mannan-induced arthritis after treatment with either PBS (r.o, n= 6) or αGC (4 μg, r.o., n= 8) at the day of arthritis induction
(indicated by arrow). (b) Clinical score (left panel) and change in ankle thickness (right panel) in IFN-γ-KO (Ifng−/−) SKG mice with mannan-induced
arthritis after treatment with either PBS (r.o., n= 5) or αGC (4 μg, r.o., n= 6). αGC was injected as above. c Clinical score (left panel) and change in ankle
thickness (right panel) in SKG mice with mannan-induced arthritis treated with either vehicle control (i.p. n= 8) or 7DW8-5 (4 μg, i.p., n= 8) 17 days after
mannan injection (indicated by arrow). Compiled data from at least three independent experiments are shown. Graphs represents mean ± SEM. *p < 0.05,
**p < 0.01 ***p < 0.001, ****p < 0.0001. (Mann–Whitney on the area under curve (a, b), Two-way ANOVA (c))
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maintain the high expression of PLZF critical for NKT2 and
NKT17 cell development. We note that TCR signal strength is
not the only influence on iNKT cell subsets, and it is well
established that cytokines are also important, such as the IL-17RB
subunit of the IL-25 receptor for NKT2 cells and IL-15 signaling
for NKT1 cells.
Our conclusion regarding the reduced requirement for TCR
signal strength for NKT1 cells is consistent with a recent study
that used retrogenic mice to assess the effect of expression of a
single TCRβ chain on iNKT cell subsets. Expression of a TCRβ
chain that imparted an increased TCR half-life for binding to
αGC tetramers and increased conjugate formation with CD1d+
thymocytes, correlated with an increase in NKT2 cells56. How-
ever, only a few engineered TCRs were sampled and the in vitro
binding assays may not reflect the in vivo interactions between
endogenous ligands and iNKT cell precursors. Another group
reported that expression of CD5 and the Nurr77 reporter for TCR
activation both were increased in NKT2 cells36, but the data did
not distinguish if this was a requirement for the NKT2 cell
population, or a result of their tonic stimulation after differ-
entiation. We also detected a higher Nur77gfp reporter signal from
NKT2-like cells in FTOC compared to NKT1-like cells, however,
stage 0 iNKT cells had a much higher reporter signal. These data
suggest that the highest TCR signals were achieved during the
initial positive selection of iNKT cells, but also are consistent
with our evidence that stronger signals are required by NKT2 as
opposed to NKT1 cells throughout their differentiation and
expansion.
We found that iNKT cells from SKG mice protected from
severe, mannan-accelerated disease, and that the protection
imparted by prophylactic αGC injection required IFNγ. Addi-
tionally, the 7DW8-5 antigen, previously reported to induce an
even more IFNγ-skewed response than αGC, exhibited ther-
apeutic potency, in contrast to αGC. Arthritis in SKG mice is due
to autoreactive T cells that produce IL-17, and therefore, our data
are consistent with other findings indicating that high levels of
IFN-γ can suppress IL-17 secretion and that IFN-γ is protective
in arthritis models53,54. The protective IFN-γ induced by iNKT
cell stimulation need not be entirely from iNKT cells, as NK cells
and other cells can be induced to produce IFN-γ downstream of
iNKT cell activation.
Despite their ability to prevent severe arthritis, iNKT cells from
SKG mice were less responsive than WT cells to antigenic sti-
mulation. The transcriptomic analysis indicated that SKG
NKT1 cells may have adapted during differentiation to decreased
TCR signaling, including a reduction in the expression of inhi-
bitory receptors and molecules transducing inhibitory signals.
The decrease in inhibitory signaling may be responsible for the
increased IFN-γ response SKG iNKT cells show to TCR-
independent inflammatory signals, such as exposure to LPS or
IL-12. The adaptation of SKG thymic iNKT cells to reduced TCR
signals is indicative of the broad effects on T cell selection in SKG
mice, including changes in the TCR repertoire due to increased
secondary rearrangements to distal Traj segments. Therefore, we
propose that the increased number of NKT1 cells in SKG mice,
their reduction in inhibitory receptors, and their enhanced
response to inflammatory cytokine signals, may have allowed
them to compensate for their partially impaired TCR signaling in
protecting these mice from severe arthritis.
In previous studies using collagen-induced arthritis (CIA),
iNKT-deficient mice developed ameliorated rather than enhanced
disease57. It is known that CIA relies on immunization and
generation of antigen-specific antibodies for disease pathogenesis.
iNKT cells are a significant inducer of humoral responses in
several contexts58,59, therefore, the reduced development of CIA
in iNKT-deficient mice could be due to an impaired induction of
autoantibody production. In adjuvant induced arthritis, however,
regulatory B cell–iNKT cell interactions ameliorated disease
through stimulation of IFN-γ60. The etiology and immuno-
pathological mechanism are entirely different in SKG mice, in
which autoimmune T cells resulting from defective thymic
selection drive disease9. Different mouse models of RA, including
CIA and SKG, may recapitulate different aspects of RA patho-
genesis that can variably dominate disease development among
patients61. Thus, the above-mentioned differences between CIA
and SKG also suggest that the protective role of iNKT cells in RA
might be more prominent in specific patient subsets.
In the absence of immunization with exogenous antigen, the
activity of iNKT cells did not completely prevent arthritis. As
disease progressed, Th17-driven immune responses increased in
SKG mice and NKT17 cells became more prevalent in the ankle
at the expense of NKT1 cells. It is not known if this dynamic
change is caused by cell recruitment or the ability of NKT1 cells
to become NKT17 cells, nor is it known if the NKT17 cells make
an important contribution to pathogenesis. Regardless, this
change clearly reflects a diminution of iNKT cell protective
capacity. We observed a capacity for IFN-γ production from
iNKT cells from the synovial fluid of RA patients, but interest-
ingly, this was reduced compared to iNKT cells from PB of the
same patients. Large scale studies will be required, however, to
determine if the prevalence of iNKT cells capable of producing
IFN-γ in synovial fluid or joint tissue correlates with disease
severity in patients. Nevertheless, the ability of circulating
iNKT cells from patients to produce this cytokine, and the
therapeutic effect of an antigen inducing the highest amount of
IFN-γ in mice, suggest that boosting IFN-γ from iNKT cells, or
from other innate-like T cells such as MAIT cells, could have
therapeutic benefit.
In conclusion, our study highlights how thymic maturation of
T cells influences the effector functions of various T cell popu-
lations, including innate-like T cells, which orchestrate complex
immune responses. The study also shows how the severity of
an inflammatory disease process can be influenced by thymic
selection. Therefore, understanding the mechanism of T cell
differentiation could have important implications for designing
therapeutic interventions in human disease.
Methods
Mice. SKG mice were obtained from S. Sakaguchi (Osaka University). For com-
parisons between WT and SKG, BALB/cJ mice from Jackson Laboratories (Jax
000651) were crossed with SKG mice to generate an F1. WT and SKG from F2
offspring were bred separately to generate WT and SKG F3, which were used in
this study. ZAP70AS mice were obtained from A. Weiss (UCSF), and the WT
controls and AS mice used in this study were the F3 offspring from backcrossing
ZAP70AS to C57BL/6J (JAX 000664) as described above. BALB/c Cd1d−/−
(C.129S2-Cd1tm1Gru/J), BALB/c CD45.1 (CByJ.SJL(B6)-Ptprca/J), and BALB/c Ifng
−/− (C.129S7(B6)-Ifngtm1Ts/J) mice were all obtained from Jackson Laboratories.
BALB/c Rag2−/− mice were purchased from Taconic. Mice were bred and housed
at the La Jolla Institute for Allergy and Immunology (LJI) vivarium and the Altman
Clinical and Translational Research Institute vivarium (ACTRI) at UCSD under
specific pathogen free conditions (SPF). All experiments were conducted in
accordance with the protocol approved by the Institutional Animal Care and Use
Committees of LJI and UCSD.
Flow cytometry and antibodies. Single-cell suspensions were prepared from
thymus, spleens and lymph nodes. For isolation of synovial cells, joints (wrist and/
or ankles) were collected, the tibia and digits removed and remaining pieces rinsed
with RPMI1640 (Corning) to avoid bone marrow contamination. Joints were
dissociated with Liberase TM (Roche) at 37 °C. Before antibody staining cells were
pre-incubated with Fc block (BD Biosciences). CD1d-αGC tetramers were prepared
in our laboratory as described previously62 and used at a dilution of 1:200. Staining
for transcription factors was performed using reagents and protocols from the
Transcription Factor (TF) Buffer Set (BD Biosciences). For intracellular cytokine
staining, Cell Fixation/Permeabilization kit (BD Biosciences) was used. Prolifera-
tion of DP cells was examined using BD PharMingen BrdU Flow Kits. Briefly, 0.7
mg of BrdU solution (10 mg/ml) was injected i.p. into each mouse, and 20 h later,
incorporation in thymocytes was examined following manufacturer’s protocol.
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Apoptosis of DP cells was examined using APC Annexin V (BD PharMingen) and
supporting protocols. The complete list of other antibodies and reagents used is as
follows: Live/Dead-Yellow (ThermoFisher), Fixable viability dye (ThermoFisher),
anti-TCRβ (H57-597), anti-CD4 (RM4-5), anti-CD8α (53–6.7), anti-CD19 (6D5),
anti-CD24 (M1/69), anti-CD44 (IM7) and anti-NK1.1 (PK136), anti-CXCR3
(CXCR3-173), anti-CD49A (Ha31/8), anti-CD122(TM-beta1), anti-CD5(53–7.3),
anti-PD-1(29F.1A12), anti-ICOS (C398.4A), anti-CD1d(1B1), anti-CD69(H1.2F3),
anti-Sdc-1(281–2), anti-CD160(eBioCNX46-3), anti-Tigit(GIGD7), anti-NKG2A/
C/E(20d5) anti-IFN-γ (XMG1.2), anti-IL-4 (BVD6-24G2), anti-IL-17A
(TC11-18H10.1 and eBio17B17), anti-PLZF (R17-809), anti-T-bet (O4-46), anti-
RORγt (Q31-378 or B2D), anti-Eomes (Dan11mag), anti-Egr2 (erongr2),
anti-Ly49G2 (4D11). Stained samples were analyzed using either LSRII or Fortessa
flow cytometers (BD Biosciences) or a ZE5 (Bio-Rad) flow cytometer and FlowJo
software (Treestar).
In vitro and in vivo cytokine production. For in vitro αGC stimulation, purified
CD1d protein was used to coat microwells at 10 μg/ml in PBS at 37 °C for 1 h, then
the plate was washed with T cell culture medium TCM (RPMI medium supple-
mented with 10% (vol/vol) FBS, 50 μM β-mercaptoethanol, 50 μg/ml penicillin/
streptomycin/glutamine mix, 10 mM Hepes, 1× MEM nonessential amino acids, 1
mM sodium pyruvate). Thymocytes were enriched for iNKT cells by negative
selection of CD8β+ CD62L+ cells. The remaining cells were suspended at 108/ml,
incubated with 1 μg/ml of Streptavidin A (Sigma-Aldrich) and washed once with
TCM. Enriched thymocytes were added to the CD1d coated wells at 2 × 106/ml
with αGC at 0.5 μg/ml. Cells were incubated for 4 h at 37 °C with Brefeldin A
(Sigma-Aldrich) added for the final 2 h. For in vitro stimulation with PMA and
ionomycin, thymocytes were enriched as above and incubated with PMA (phorbol
12-myristate 13-acetate; 50 ng/ml) and ionomycin (1.5 μM) for 4 h with Brefeldin
A (Sigma-Aldrich) added for the final 2 h, and intracellular cytokines were ana-
lyzed by flow cytometry. For in vivo stimulation of iNKT cells, mice were injected
i.v. with 1 μg αGC (α-galactosylceramide or KRN7000, Kirin Hakko Kirin Cali-
fornia) and spleens were analyzed 1.5 h later. For in vivo LPS challenge, mice were
injected i.v. with 50 μg lipopolysaccharide (LPS) from Salmonella enterica (Sigma-
Aldrich) and spleens were analyzed at 2, 4, and 6 h after injection.
Synovial cells and cells isolated from joint-draining lymph nodes (brachial,
axillary and popliteal) from arthritic SKG mice were activated in vitro with PMA
and ionomycin as described above.
For in vitro IL-12 stimulation, single-cell suspensions were prepared from
pooled lymph nodes (brachial, axillary, inguinal, and popliteal) from WT, SKG,
and SKG mice with mannan-induced arthritis. Cells (5 × 106/ml) were stimulated
for 48 h with 20 ng/ml recombinant mouse IL-12 (R&D Systems) and Brefeldin A
was added for the last 7 h of stimulation.
Mixed bone marrow chimeras. Total bone marrow cells were prepared from the
femurs and tibias of wild-type BALB/c (CD45.1+) or SKG (CD45.2+) donor mice,
and samples were depleted of mature T cells with anti-Thy1.2 (30-H12; BD).
Recipient F1 mice (CD45.1+CD45.2+) were pretreated with sulfatrim in drinking
water 3 days prior, lethally irradiated (900 rads) and received 10 × 106 T cell-
depleted bone marrow cells. Chimeras were maintained on drinking water with
sulfatrim and analyzed 6 weeks after transplantation.
Calcium flux assay. As described63, thymocytes from WT mice were labeled with
CFSE (20 nM) in PBS for 10’ at 37 °C, washed and mixed with thymocytes from
SKG mice(CSFE−) at 1:1 ratio. Cells were then loaded with Indo-1 AM
(ThermoFisher) 2 uM with 4 μM probenecid (ThermoFisher) in RPMI with 1%
FBS. After washing, cells were stained with antibodies against CD4 and CD8α as
well as biotinylated anti-CD3ε antibodies (10 μg/ml, 145-2C11; Biolegend) on ice.
The cells were stimulated by streptavidin crosslinking in PBS and calcium flux was
initiated after addition of CaCl2(5 mM). The mean fluorescence ratio of Indo-1
violet to Indo-1 blue was calculated using FlowJo software (Tree Star, Inc).
Thymic organ culture. Timed breedings were set up and thymic lobes were har-
vested from e18.5 embryos or d0 mice. Lobes were cultured on cell culture inserts
with a 0.4 μm pore in 6-well culture dishes (Sigma #CLS3450) on top of 1.5 ml
complete DMEM supplemented with 10% FBS, 50 μM β-mercaptoethanol, 50 μg/ml
penicillin/streptomycin/glutamine mix, 10 mM Hepes, 1× MEM nonessential
amino acids and 1 mM sodium pyruvate. Media containing DMSO or various
concentrations of 3-MB-PP1 was exchanged daily until thymic lobes were dis-
sociated into single-cell suspensions for staining with antibodies for flow cyto-
metric analysis.
Compounds. 3-MB-PP1 (3-methylbenzyl-pyrazolopyrimidine) was purchased
from Millipore (#529582). 7DW8-5 [(2S,3S,4R)-1-O-(α-D-galactopyranosyl)-N-
(11-(4-fluorophenyl)undecanoyl)-2-amino-1,3,4-octadecanetriol)] was purchased
from Diagnocine (#7DW8-5).
Isolation of iNKT cell subsets and pre-selection DP cells. For RNA isolation of
thymic iNKT cell subsets, as described previously12, thymocytes from WT and SKG
mice were enriched for iNKT cells and stained with Live/dead-yellow dye and
antibodies against other surface markers. iNKT subsets were sorted using a
FACSAria Fusion (BD Biosciences) as in Supplementary Fig. 6: NKT1, CD1d-
αGCtetramer+ICOSloCD49a+; NKT2, CD1d-αGCtetramer+CD49−Sdc-1−ICOSh-
iCD4hiTCRβhi; NKT17, CD1d-αGCtetramer+CD49−ICOShiSdc-1+. Pre-selection
DP cells were sorted as CD4+CD8α+TCRβ−CD69−CD5− from un-enriched
thymocytes.
RNA-sequencing. Sorted cells were lysed in Trizol LS (ThermoFisher), RNA was
prepared using miRNeasy micro kit from Qiagen and quantified as described
previously64. Adapted from the Smart-seq2 protocol65, an oligo-based capture
of Poly-A tailed mRNA was carried out followed by a high-fidelity reverse
transcription using locked nucleic acids (LNA)-oligos to obtain full-length
transcripts. mRNA complementary (c)DNA strands were then amplified using a
PCR-based method and sequencing adaptors incorporated into the cDNA
fragments in a single step using Tn5 transposase technology (Nextera XT reagents
and barcoded adaptors kits). Libraries were sequenced on the HiSeq2500 Illumina
platform to obtain 50-bp single-end reads (TruSeq® Rapid Kit, Illumina).
RNA-seq analysis. The single-end reads that passed Illumina filters were filtered
for reads aligning to tRNA, rRNA, adapter sequences, and spike-in controls. The
reads were then aligned to UCSC mm9 reference genome using TopHat (v 1.4.1).
DUST scores were calculated with PRINSEQ Lite (v 0.20.3) and low-complexity
reads (DUST > 4) were removed from the BAM files. The alignment results were
parsed via the SAMtools to generate SAM files. Read counts to each genomic
feature were obtained with the htseq-count program (v 0.6.0) using the “union”
option. After removing absent features (zero counts in all samples), the raw counts
were then imported to R/Bioconductor package DESeq2 to identify differentially
expressed genes among samples. DESeq2 normalizes counts by dividing each
column of the count table (samples) by the size factor of this column. The size
factor is calculated by dividing the samples by geometric means of the genes. This
brings the count values to a common scale suitable for comparison. p-values for
differential expression are calculated using binomial test for differences between the
base means of two conditions. These p-values are then adjusted for multiple test
correction using the Benjamini Hochberg algorithm to control the false discovery
rate. We considered genes differentially expressed between two groups of samples
when the DESeq2 analysis resulted in an adjusted p-value of <0.1 and the fold
change in gene expression was 1.5-fold.
Gene set enrichment analysis. The TCR pathway-related gene set was converted
to .gmx format. Log to the base 10 of p values for all genes were calculated and the
sign was changed when there was a negative logfoldchange. These data were used
to create the .rnk file. Both gene_sets.gmx and DE.rnk files were loaded in the
GSEA GUI and the following parameters were set before running GSEA on a Pre-
Ranked gene list (other parameters have default settings): Collapse data set to gene
symbols: set as false; Enrichment statistic: classic
Heatmaps, PCA, and MA plots. A row-scaled heatmap of log-transformed RPKM
values was created with the heatmap.2 function in the gplots v3.0.1 library under R
v3.4.2. Hierarchical clustering of samples was done with the ‘hclust’ function using
average linkage. In order to show the expression level of NK receptors in iNKT cells
(Fig. 4c), an unscaled heatmap of log-transformed RPKM values was created as
above. The genes were arranged in a decreasing order of the average expression
level in WT NKT1 samples. PCA was performed using the 'prcomp' function in R,
setting the 'scale' parameter to TRUE. (Shiny PCA Maker: https://github.com/LJI-
Bioinformatics/Shiny-PCA-Maker). The MA plots were created with ggplot func-
tion in the package ggplot2 v2.2.1 under R v3.4.2. We plotted log2 of baseMean and
shrunken log2foldchange (both calculated via DESeq2) on the x and y axis,
respectively. A fold change cutoff of 1.5 and p-value cut off of 0.1 was applied to
color code differentially expressed genes on the plot. The gene names were added
using function geom_text_repel in the library ggrepel v0.7.0.
TCR sequencing. Pre-selection DP cells from WT or SKG mice were sorted and
RNA was extracted as above. cDNA was prepared from RNA with SuperScript III
(ThermoFisher). PCR was performed for amplification of the Trav9, Trav11, and
Trav19 gene segments with specific forward primers for each Vα region (each with
an Illumina adaptor sequence on the 5’ end: Trav9, GCTGCAGCTGCTCCT-
CAAGT; Trav11, AACAGGACACAGGCAAAG; Trav19, GCTGACTGTTCAA-
GAGGGA) and a reverse primer for the α-chain constant region (also with an
Illumina adaptor sequence on the 5’ end; GCACATTGATTTGGGAGTC). PCR
products were purified and sequenced on a Miseq system with a MiSeq Reagent Kit
v2-500 (Illumina). The paired-end FASTQ files were run through MIXCR v1.8.3 to
get clonal sequences which were then primer trimmed using cutadapt version 1.13.
These sequences were de-duplicated by removing exact matches. IMGT/HighV-
QUEST v1.5.6 was used with default options to determine V and J regions and
their usage in the clonal sequences. Libraries greater than 500,000 sequences were
split up and run through HighV-Quest separately. The file named "3_Nt-sequences.
txt" was used from the output generated by HighV-Quest to process the results.
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Arthritis models. For mannan-induced arthritis in SKG mice, male and female
mice were injected i. p. with 20 mg of mannan (Sigma-Aldrich), dissolved in sterile
PBS at 8 weeks of age. Clinical scoring and measurement of ankle thickness using a
digital caliper was performed twice weekly according to an established protocol9.
Briefly, clinical signs of arthritis in front and hind paws were scored as follows: 0,
no joint swelling; 0.1 per swollen finger joint (3 digits on front paw and 4 digits on
hind paw); 0.5, mild swelling of wrist or ankle; 1.0, severe swelling of wrist or ankle.
Scores for all fingers of forepaws and hind paws, wrists and ankles were combined
for each mouse yielding a maximum score of 5.4, which was considered the clinical
endpoint. All arthritis studies were performed on littermate mice. Mice reaching
clinical endpoint scores were sacrificed according to ethical guidelines. Treatment
regime and genotypes of mice were blinded to the researcher performing the
clinical scoring of arthritis.
For treatment with αGC, mice were injected either on the day of mannan
injection (day 0) by retro-orbital injection (r.o, 100 μl) or after establishment of
arthritis (day 17) by intraperitoneal injection (i.p, 100 μl). αGC was reconstituted in
dH20 to 200 μg/ml and diluted in PBS to 40 μg/ml before injection. PBS was used
as control for αGC. For treatment with 7DW8-5 (Funakoshi Co. Ltd, Japan) mice
were injected either on the day of mannan injection (day 0) by i.p injection (100 μl)
or after establishment of arthritis (day 17) by i.p. injection (100 μl). 7DW8-5 was
reconstituted in DMSO to 25 mg/ml and diluted in PBS to 40 μg/ml before
injection (final concentration of DMSO <0.2%). PBS with equal concentration of
DMSO (Vehicle) was used as control for 7DW8-5.
Depletion of iNKT cells in WT SKG mice was achieved through injection with
anti-mouse monoclonal NKT14 antibody (200 μg) obtained from NKT
Therapeutics. Mouse IgG2a isotype control (BioXcell) was used as recommended
by NKT Therapeutics. The NKT14 antibody has previously been shown to
selectively deplete iNKT cells49,66. iNKT cells were depleted 2 days before injection
of mannan (day −2) and repeated at day 14 after mannan injection. Depletion of
iNKT cells were verified by flow cytometric identification of TCRβ+CD1d-αGC
tetramer+ cells in joint-draining lymph nodes.
iNKT and CD4 T cell transfer to RAG2-KO mice. CD4 T cells were sorted by
flow cytometry from the spleen and lymph nodes of female CD45.1 SKG mice and
iNKT cells were sorted from the thymus of CD45.2 SKG mice. CD4 T cells (1 ×
106) were transferred either alone or in combination with iNKT cells (3 × 105) to
Rag2−/− mice by r.o injection. One week after transfer mice were injected with 20
mg of mannan to induce development of arthritis. Clinical scoring of arthritis was
performed in a blinded manner as described above.
Histological assessment of arthritic joints. Hind paws were fixed in 10%
neutral-buffered formalin, decalcified, and embedded in paraffin. Sections were
prepared from tissue blocks by the LJI histology facility and stained with H&E and
safranin-O/Fast Green/Hematoxylin (Sigma-Aldrich). Histopathological scoring
for inflammation, bone erosion, and cartilage erosion was performed in a blinded
manner as previously described67.
Micro-CT. Ankles were place in 10% neutral-buffered formalin. After fixation,
samples were transferred to 70% ethanol. Before scanning, bones were transferred
to PBS for 48 h. Scanning was performed on a Skyscan1176 micro-CT (Bruker,
Antwerp, Belgium) with a voxel size of 9 μm, at 50 kV/ 200 mA, with a 0.5 mm
aluminum filter. Exposure time was 810 ms. The X-ray projections were obtained
at 0.4° intervals with a scanning angular rotation of 180° and a combination of 4
average frames. The projection images were reconstructed into 3D images using
NRECON software (Bruker) and CT-Analyzer (Bruker). Images were generated
using the CT-VOX software (Bruker).
Human iNKT cells. Paired synovial fluid (SF) and peripheral blood (PB)
samples were obtained from eight patients with definitive rheumatoid arthritis
(RA), fulfilling the EULAR/ACR2010 criteria (Supplementary Table 1). This study
was approved by the local ethics committee of Ghent University Hospital (Bel-
gium) and all patients gave written informed consent. Blood and SF samples were
diluted in RPMI medium and mononuclear cells (MC) were isolated by density
gradient centrifugation using histopaque®-1077 (Sigma-Aldrich). iNKT cells were
defined as live CD3+CD19− TCRVα24Jα18+TCRVβ11+ cells detected within the
lymphocyte gate of PBMC and SFMC samples using the L/D stain 7-AAD (BD)
and the following monoclonal antibodies: anti-human CD3 APC-eFluor780
(UCHT1), CD19 PERCP-Cy5.5 (HIB19), TCRVα24Jα18 PE (6B11, all from
eBiosciences) and TCRVβ11 FITC (C21, Beckman Coulter). Samples were acquired
on a FACS Canto II flow cytometer (BD) and analyzed by means of FlowJo
10.3 software (Treestar).
For evaluation of IFN-γ production by iNKT cells directly ex vivo, freshly
isolated PBMC and SFMC were incubated for 4 h with phorbol 12-myristate 13-
acetate (PMA, 25 ng/ml), calcium-ionomycin (CaI, 1 µg/ml; both from Sigma) and
brefeldin A (BFA, 10 ng/ml; BD) or BFA alone (negative control). Cells were
prepared for intracellular cytokine staining as described before68 using the Cytofix/
Cytoperm kit (BD), L/D Fixable Violet Dead Cell Stain Kit (ThermoFisher) and
anti-human IFN-γ PERCP-Cy5.5 mAb (45.B3, eBioscience).
In separate experiments, 3 × 106 PBMC and SFMC were incubated for 48 h with
αGC (100 ng/ml; Laboratory for Medicinal Chemistry, Ghent University) and IFN-
γ levels were measured in supernatants of PB and SF cell cultures by means of
ELISA (eBioscience).
Statistics. Sample sizes were selected based upon our experience with the above-
mentioned assays in order to achieve sufficient power to detect biologically
relevant differences in the experiments being conducted with an α error (two
tailed) <0.05.
For statistical analysis, a 2-tailed Mann–Whitney test was performed on non-
parametric data. On normal distributed data 2-tailed unpaired t test, one way
ANOVA or paired t test were performed as reported in the figure legends.
Spearman test was used for calculation of correlations. All statistical analyses were
performed using GraphPad Prism software. A comparison was considered
significant if p < 0.05.
Data availability. RNA-seq data in this study have been deposited in GEO with the
accession codes GSE114555 and TCR-seq data have been deposited have been
deposited in GEO with the accession codes GSE114595. Other data that support
the findings of this study are available from the corresponding authors upon
reasonable request.
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